Červenka L - Search Results

1

Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.

Červenka L, Husková Z, Kopkan L, Kikerlová S, Sedláková L, Vaňourková Z, Alánová P, Kolář F, Hammock BD, Hwang SH, Imig JD, Falck JR, Sadowski J, Kompanowska-Jezierska E, Neckář J. Červenka L, et al. J Hypertens. 2018 Jun;36(6):1326-1341. doi: 10.1097/HJH.0000000000001708. J Hypertens. 2018. PMID: 29570510 Free PMC article.

2

Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade.

Navar LG, Harrison-Bernard LM, Imig JD, Wang CT, Cervenka L, Mitchell KD. Navar LG, et al. Among authors: cervenka l. J Am Soc Nephrol. 1999 Apr;10 Suppl 12:S266-72. J Am Soc Nephrol. 1999. PMID: 10201881 Review.

3

Early onset salt-sensitive hypertension in bradykinin B(2) receptor null mice.

Cervenka L, Harrison-Bernard LM, Dipp S, Primrose G, Imig JD, El-Dahr SS. Cervenka L, et al. Hypertension. 1999 Aug;34(2):176-80. doi: 10.1161/01.hyp.34.2.176. Hypertension. 1999. PMID: 10454437

4

Renal responses to AT1 receptor blockade.

Navar LG, Harrison-Bernard LM, Imig JD, Cervenka L, Mitchell KD. Navar LG, et al. Among authors: cervenka l. Am J Hypertens. 2000 Jan;13(1 Pt 2):45S-54S. doi: 10.1016/s0895-7061(99)00248-4. Am J Hypertens. 2000. PMID: 10678288 Review.

5

Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice.

Cervenka L, Maly J, Karasová L, Simová M, Vítko S, Hellerová S, Heller J, El-Dahr SS. Cervenka L, et al. Hypertension. 2001 Mar;37(3):967-73. doi: 10.1161/01.hyp.37.3.967. Hypertension. 2001. PMID: 11270390

6

Role of nNOS in regulation of renal function in angiotensin II-induced hypertension.

Cervenka L, Kramer HJ, Malý J, Heller J. Cervenka L, et al. Hypertension. 2001 Aug;38(2):280-5. doi: 10.1161/01.hyp.38.2.280. Hypertension. 2001. PMID: 11509490

7

Essential role of AT1A receptor in the development of 2K1C hypertension.

Cervenka L, Horácek V, Vanecková I, Hubácek JA, Oliverio MI, Coffman TM, Navar LG. Cervenka L, et al. Hypertension. 2002 Nov;40(5):735-41. doi: 10.1161/01.hyp.0000036452.28493.74. Hypertension. 2002. PMID: 12411470

8

Genetic inactivation of the B2 receptor in mice worsens two-kidney, one-clip hypertension: role of NO and the AT2 receptor.

Cervenka L, Vanecková I, Malý J, Horácek V, El-Dahr SS. Cervenka L, et al. J Hypertens. 2003 Aug;21(8):1531-8. doi: 10.1097/01.hjh.0000084716.53355.c4. J Hypertens. 2003. PMID: 12872048

9

Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.

Kopkan L, Kramer HJ, Husková Z, Vanourková Z, Bäcker A, Bader M, Ganten D, Cervenka L. Kopkan L, et al. Among authors: cervenka l. J Hypertens. 2004 Apr;22(4):819-25. doi: 10.1097/00004872-200404000-00026. J Hypertens. 2004. PMID: 15126925

10

Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.

Vanecková I, Cahová M, Kramer HJ, Husková Z, Skaroupková P, Komers R, Bader M, Ganten D, Cervenka L. Vanecková I, et al. Among authors: cervenka l. Kidney Blood Press Res. 2004;27(4):203-10. doi: 10.1159/000079865. Epub 2004 Jul 20. Kidney Blood Press Res. 2004. PMID: 15273422

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page